Japan In Vitro Fertilisation (IVF) Service Market Insights Forecasts to 2033

• The Japan In Vitro Fertilisation (IVF) Service Market Size was valued at USD 245.13 Million in 2023.
• The Market Size is Growing at a CAGR of 8.46% % from 2023 to 2033
• The Japan In Vitro Fertilisation (IVF) Service Market Size is Expected to reach USD 552.10 Million by 2033

The Japan In Vitro Fertilisation (IVF) Service Market Size is Anticipated to reach USD 552.10 Million by 2033, growing at a CAGR of 8.46% % from 2023 to 2033.

Market Overview

Assisted reproductive technology (ART) includes procedures including in vitro fertilization (IVF). It is taking the fertilized eggs out of the ovaries of the woman and fertilizing them with sperm. An embryo is an egg that has been fertilized. The embryo can subsequently be implanted into a woman's uterus or preserved for later use. IVF, or in vitro fertilization, is a sophisticated set of processes that has the potential to result in pregnancy. It is an infertility treatment, a disorder in which most couples are unable to conceive despite at least a year of trying. It is also possible to avoid passing on genetic issues to a child through IVF. The mature eggs are removed from ovaries undergoing in vitro fertilization, and sperm fertilizes them in a laboratory. After that, a process is carried out to implant one or more of the fertilized eggs, also known as embryos, into the uterus, which is where infants are developed. It takes two to three weeks for an IVF cycle to complete.

Report Coverage

This research report categorizes the market for Japan in vitro fertilisation (IVF) service market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan in vitro fertilisation (IVF) service market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan in vitro fertilisation (IVF) service market.

Driving Factors

The number of treatment cycles overall and live births over the prior year increased significantly in 2021, according to a review of the Japanese assisted reproductive technology (ART) database. Additionally, Yoshihide Suga, Japan's novel prime minister, has offered hope to infertile couples by promising to pay for costly reproductive therapies using health insurance. Furthermore, Japan's average lifelong birth rate, or the average amount of children a woman has, was 1.36 last year much lower than the 2.1 required to maintain population stability. The Japanese government has highlighted more affordable access to IVF as a potential remedy and wants to improve the rate to 1.8.

Restraining Factors

One of the key obstacles to the market's expansion is still the expense of IVF treatments. Fertility treatments and specialist reproduction medical professionals are not evenly distributed throughout Japan; large urban centers such as Tokyo and Osaka have a higher concentration of these facilities.

Market Segmentation

The Japan in vitro fertilisation (IVF) service market share is classified into type and end user.

• The fresh IVF cycle segment is expected to hold a significant market share through the forecast period.    

The Japan in vitro fertilisation (IVF) service market is segmented by type into fresh IVF cycle, thawed IVF cycle, and donor egg IVF cycle. Among these, the fresh IVF cycle segment is expected to hold a significant market share through the forecast period. Fresh IVF cycles have a greater rate of success in comparison with frozen cycles due to the eggs are extracted and fertilized right before being delivered to the womb.

• The fertility clinics segment is anticipated to hold a significant share of the Japan in vitro fertilisation (IVF) service market during the forecast period.       

Based on the end user, the Japan in vitro fertilisation (IVF) service market is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. Among these, the fertility clinics segment is anticipated to hold a significant share of the Japan in vitro fertilisation (IVF) service market during the forecast period. Fertility Clinics are regarded as the market leader in Japan for in vitro fertilization services due to the rapid advancement of technology and the growing popularity of smart devices that integrate and connect to the internet.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan in vitro fertilisation (IVF) service market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Fertility Clinic Tokyo
• Kiba Park Clinic
• Shinjuku ART Clinic
• Megumi Clinic
• Sanno Hospital
• Keio University Hospital
• St. Luke’s International Hospital
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan In Vitro fertilization (IVF) Service Market based on the below-mentioned segment:

Japan In Vitro Fertilisation (IVF) Service Market, By Type

• Fresh IVF Cycle
• Thawed IVF Cycle
• Donor Egg IVF Cycle

Japan In Vitro Fertilisation (IVF) Service Market, By End User

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Researc